Generalized Lysosome-Associated Membrane Protein-2 Defect Explains Multisystem Clinical Involvement and Allows Leukocyte Diagnostic Screening in Danon Disease
- 30 April 2006
- journal article
- case report
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 168 (4), 1309-1320
- https://doi.org/10.2353/ajpath.2006.050646
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 geneNeuromuscular Disorders, 2005
- Morphological, clinical and genetic aspects in a family with a novel LAMP-2 gene mutation (Danon disease)Neuromuscular Disorders, 2005
- A new function for nonsense-mediated mRNA-decay factorsTrends in Genetics, 2005
- Cytoplasmic nonsense-mediated mRNA decay for a nonsense (W262X) transcript of the gene responsible for hereditary tyrosinemia, fumarylacetoacetate hydrolaseBiochemical and Biophysical Research Communications, 2004
- Molecular diagnosis in LGMD2A: Mutation analysis or protein testing?Human Mutation, 2004
- Loss of Calpain-3 Autocatalytic Activity in LGMD2A Patients with Normal Protein ExpressionThe American Journal of Pathology, 2003
- Identification of a NovelLAMP2Mutation Responsible for X-Chromosomal Dominant Danon DiseaseNeuropediatrics, 2003
- Role of LAMP-2 in Lysosome Biogenesis and AutophagyMolecular Biology of the Cell, 2002
- An Alternatively Spliced Form of the Human Lysosome-Associated Membrane Protein-2 Gene Is Expressed in a Tissue-Specific MannerBiochemical and Biophysical Research Communications, 1995
- Identification of two lysosomal membrane glycoproteins.The Journal of cell biology, 1985